Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
MNKD
$5.54
+4.53%
Analyze
1M
+0.2%
3M
+36.5%
1Y
-15.3%
Market Cap:
$1.70B
MannKind Corp
Healthcare |
Biotechnology
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.
Click "Analyze" to generate stock analysis
MNKD Price Trend and Signals
MNKD Option Volumes & Open Interests (aggregated)
MNKD Put Call Ratios and IV (aggregated)
MNKD Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-10
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-09
Somewhat Bearish
price_signal
Monthly low detected.